title: Ethics of clinical science in a public health emergency: drug discovery at the bedside.
abstract: Clinical research under the usual regulatory constraints may be difficult or even impossible in a public health emergency. Regulators must seek to strike a good balance in granting as wide therapeutic access to new drugs as possible at the same time as gathering sound evidence of safety and effectiveness. To inform current policy, I reexamine the philosophical rationale for restricting new medicines to clinical trials, at any stage and for any population of patients (which resides in the precautionary principle), to show that its objective to protect public health, now or in the future, could soon be defeated in a pandemic. Providing wider therapeutic access and coordinating observations and natural experiments, including service delivery by cluster (wedged cluster trials), may provide such a balance. However, there are important questions of fairness to resolve before any such research can proceed.
authors: University College London, UK. sarah.edwards@ucl.ac.uk
authors: Sarah J L
authors: SJ
authors: Edwards
mesh_terms: D035843:Biomedical Research / Q000941:ethics*; D055808:Drug Discovery / Q000941:ethics* / Q000331:legislation & jurisprudence*; D015507:Drugs, Investigational; D004630:Emergencies; D032984:Ethics, Research; D015276:Health Care Rationing / Q000941:ethics; D054624:Health Status Disparities; D006801:Humans; D058873:Pandemics; D011634:Public Health; D016032:Randomized Controlled Trials as Topic / Q000941:ethics*; D012935:Social Justice; D036302:Therapeutic Human Experimentation / Q000941:ethics*; D014481:United States
chemical_list: D015507:Drugs, Investigational
references: Perspect Biol Med. 2008 Summer;51(3):418-31
references: 18723945
references: BMJ. 1999 May 22;318(7195):1407-9
references: 10334756
references: Clin Res. 1992 Oct;40(3):519-27
references: 1395439
references: Health Technol Assess. 1999;3(5):iii-92
references: 10982317
references: Trials. 2011 Jul 26;12:183
references: 21791064
references: Clin Infect Dis. 2009 Jun 15;48(12):1647-8
references: 19435434
references: Hastings Cent Rep. 2008 Sep-Oct;38(5):39-48
references: 18947140
references: Sci Transl Med. 2011 Feb 16;3(70):70cm5
references: 21325614
references: Clin Pharmacol Ther. 2010 Mar;87(3):356-61
references: 20130565
references: Bioethics. 2006 Apr;20(2):77-91
references: 16770878
references: Nature. 1999 Jul 29;400(6743):398
references: 10440359
references: N Engl J Med. 1987 Jul 16;317(3):141-5
references: 3600702
references: Lancet Infect Dis. 2008 Oct;8(10):650-8
references: 18922487
references: Emerg Infect Dis. 2008 Jan;14(1):88-94
references: 18258086
references: PLoS Med. 2007 May;4(5):e119
references: 17535099
references: Soc Sci Med. 2006 Apr;62(7):1768-84
references: 16226363
references: J Neurosurg. 2012 Feb;116(2):315-22
references: 22098195
references: BMC Public Health. 2007 Aug 15;7:208
references: 17697389
references: Seton Hall Law Rev. 2009;39(4):1173-202
references: 20718134
references: N Engl J Med. 2001 Mar 8;344(10):710-9
references: 11236774
references: Soc Sci Med. 1997 Nov;45(9):1337-55
references: 9351153
references: J Med Ethics. 2002 Feb;28(1):20-3
references: 11834754
references: Nat Med. 2000 Dec;6(12):1375-9
references: 11100123
references: JAMA. 2003 Dec 24;290(24):3229-37
references: 14693876
references: Emerg Infect Dis. 2004 Mar;10(3):389-94
references: 15109402
references: Disaster Manag Response. 2005 Jul-Sep;3(3):61-7
references: 15986025
references: PLoS Med. 2009 Jun 23;6(6):e1000091
references: 19554084
references: Nature. 1991 Nov 28;354(6351):255
references: 1956374
references: BMJ. 2000 Jan 1;320(7226):43-6
references: 10617532